ManipalCigna Health Insurance Investment Income Ratio
2.0%
Q1 FY26-27
ManipalCigna Health Insurance's investment income ratio was 2% for Q1 FY26-27, as reported in IRDAI form NL-20-ANALYTICAL-RATIOS.
What this measures
Net investment income as a percentage of Net Written Premium. Measures how much investment returns contribute relative to premium volume. A higher ratio supplements underwriting profitability and can offset underwriting losses.
Note: NL-20 analytical ratios. Complements the underwriting balance ratio — together they drive the operating profit ratio.
Historical Data
| Period | Value | Source form | Data as of |
|---|---|---|---|
| Q1 FY26-27 | 2.0 % | NL-20-ANALYTICAL-RATIOS | 2026-10-25 |
| Q4 FY25-26 | 2.0 % | NL-20-ANALYTICAL-RATIOS | 2026-10-31 |
| Q3 FY25-26 | 2.0 % | NL-20-ANALYTICAL-RATIOS | 2026-10-28 |
| Q2 FY25-26 | 2.0 % | NL-20-ANALYTICAL-RATIOS | 2026-10-28 |
| Q1 FY25-26 | 2.0 % | NL-20-ANALYTICAL-RATIOS | 2026-10-25 |
| Q4 FY24-25 | 7.0 % | NL-20-ANALYTICAL-RATIOS | 2026-10-25 |
| Q3 FY24-25 | 1.9 % | NL-20-ANALYTICAL-RATIOS | 2026-10-25 |
| Q2 FY24-25 | 3.7 % | NL-20-ANALYTICAL-RATIOS | 2026-10-25 |
| Q1 FY24-25 | 1.8 % | NL-20-ANALYTICAL-RATIOS | 2026-10-25 |
| Q4 FY23-24 | 7.0 % | NL-20-ANALYTICAL-RATIOS | 2026-10-25 |
| Q3 FY23-24 | 5.2 % | NL-20-ANALYTICAL-RATIOS | 2026-10-25 |
| Q2 FY23-24 | 3.5 % | NL-20-ANALYTICAL-RATIOS | 2026-10-25 |
| Q1 FY23-24 | 1.7 % | NL-20-ANALYTICAL-RATIOS | 2026-10-25 |
| Q4 FY22-23 | 6.3 % | NL-20-ANALYTICAL-RATIOS | 2026-10-25 |
| Q3 FY21-22 | 5.0 % | NL-20-ANALYTICAL-RATIOS | 2026-10-25 |
| Q2 FY21-22 | 3.0 % | NL-20-ANALYTICAL-RATIOS | 2026-10-25 |
Provenance
- Reported by
- ManipalCigna Health Insurance
- Regulatory form
- NL-20-ANALYTICAL-RATIOS · what this form contains
- Reporting period
- Q1 FY26-27
- Source document
- 07769dc0-e6ad-701d-f5b8-7716ee328184.pdf · ManipalCigna Health Insurance's disclosure page
- Extracted by
- irw_adapter v1
- Last verified
- 2026-10-25
- Note
- NL-20 row-format label match: investment_income_ratio